BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 27150598)

  • 1. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
    Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
    Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
    Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
    Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidylarginine deiminase 4 and citrullination in health and disease.
    Anzilotti C; Pratesi F; Tommasi C; Migliorini P
    Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
    Suzuki A; Yamada R; Yamamoto K
    Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
    Seri Y; Shoda H; Suzuki A; Matsumoto I; Sumida T; Fujio K; Yamamoto K
    Sci Rep; 2015 Aug; 5():13041. PubMed ID: 26293116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
    Yamada R; Suzuki A; Chang X; Yamamoto K
    Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of antibody production during collagen-induced arthritis development in heterogeneous stock mice.
    Förster M; Raposo B; Ekman D; Klaczkowska D; Popovic M; Nandakumar KS; Lindvall T; Hultqvist M; Teneva I; Johannesson M; Ahlqvist E; Holmdahl R
    Arthritis Rheum; 2012 Nov; 64(11):3594-603. PubMed ID: 22886420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
    Suzuki A; Yamada R; Chang X; Tokuhiro S; Sawada T; Suzuki M; Nagasaki M; Nakayama-Hamada M; Kawaida R; Ono M; Ohtsuki M; Furukawa H; Yoshino S; Yukioka M; Tohma S; Matsubara T; Wakitani S; Teshima R; Nishioka Y; Sekine A; Iida A; Takahashi A; Tsunoda T; Nakamura Y; Yamamoto K
    Nat Genet; 2003 Aug; 34(4):395-402. PubMed ID: 12833157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
    Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
    Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.
    Shelef MA; Sokolove J; Lahey LJ; Wagner CA; Sackmann EK; Warner TF; Wang Y; Beebe DJ; Robinson WH; Huttenlocher A
    Arthritis Rheumatol; 2014 Jun; 66(6):1482-91. PubMed ID: 24497204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.
    Bawadekar M; Gendron-Fitzpatrick A; Rebernick R; Shim D; Warner TF; Nicholas AP; Lundblad LK; Thompson PR; Shelef MA
    Arthritis Res Ther; 2016 Jul; 18(1):173. PubMed ID: 27450561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
    Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
    Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Cantaert T; Teitsma C; Tak PP; Baeten D
    Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to citrullinated antigens in autoimmune diseases.
    Migliorini P; Pratesi F; Tommasi C; Anzilotti C
    Autoimmun Rev; 2005 Nov; 4(8):561-4. PubMed ID: 16214096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination.
    Kidd BA; Ho PP; Sharpe O; Zhao X; Tomooka BH; Kanter JL; Steinman L; Robinson WH
    Arthritis Res Ther; 2008; 10(5):R119. PubMed ID: 18826638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.